Shenzhen Hepalink Pharmaceutical Group. (9989.HK) Q3 2023 Earnings

2NovExpected
Oct 22
Q1 2023
Q2 2023
Q3 2023
0
0.07
0.13
0.2

Details

Expected EPS
0.1709
Actual EPS
0
Surprise EPS
-0.17
Surprise Percent
+100%

Description

Shenzhen Hepalink Pharmaceutical Group. (9989.HK) will report earnings of for Q3 2023 on November 02, 2023.

0 Comments

Share your thoughts